2011
DOI: 10.1007/s00276-011-0854-2
|View full text |Cite
|
Sign up to set email alerts
|

Cd34-positive developing vessels and other structures in human fetuses: an immunohistochemical study

Abstract: CD34 is a well-known marker of progenitor cells of blood vessels and stromal tissues. Thus, CD34-positive cells have recently been used clinically in the field of vascular and orthopedic biotechnology because of their capacity to assist regeneration of injured tissues. However, to our knowledge, the in situ distribution of CD34-positive cells has not yet been described in the human fetus, with the exception of a few organs. In the present study, we conducted immunohistochemistry for CD34 using 12 human fetuses… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
28
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(30 citation statements)
references
References 23 publications
2
28
0
Order By: Relevance
“…Almost identical immunoreactivity is evident for CD31 molecules, the difference being that, on the endothelium, it expresses slightly later than that of CD34. Abe et al [2011] described CD34-immunopositive endothelium of the portal vein branches and CD34-immunonegative endothelium of the hepatic vein tributaries. As for the CD34 immunoreactivity of the endothelial sinusoids, our results are consistent with their findings; they partly described CD34-positive endothelial cells in sinusoids in the 15th week of development.…”
Section: Endothelial Heterogeneity In Humanmentioning
confidence: 99%
See 1 more Smart Citation
“…Almost identical immunoreactivity is evident for CD31 molecules, the difference being that, on the endothelium, it expresses slightly later than that of CD34. Abe et al [2011] described CD34-immunopositive endothelium of the portal vein branches and CD34-immunonegative endothelium of the hepatic vein tributaries. As for the CD34 immunoreactivity of the endothelial sinusoids, our results are consistent with their findings; they partly described CD34-positive endothelial cells in sinusoids in the 15th week of development.…”
Section: Endothelial Heterogeneity In Humanmentioning
confidence: 99%
“…Lalor et al [2006] contend that CD31 immunoreactivity in the endothelium of hepatic sinusoids is present only after 25 weeks of development. Abe et al [2011] indicate that CD34 is positively expressed on the endothelial cells of sinusoids starting from 15 weeks of development.…”
mentioning
confidence: 99%
“…Endothelium is a common structural component of lymph vessels and sinusoids of the liver, but during embryonal development it differentiates into two morphologically and functionally different epithelial lines characterized by the expression of different molecules -endothelial cells in the liver sinusoids express, above all, CD31 and CD34 molecules (16,17), while endothelial cells of the lymph vessels express LYVE-1 (8,18,19) and D2-40 molecules (20,21).…”
Section: Discussionmentioning
confidence: 99%
“…At an embryological level, the deep fascia surrounding the developing muscles has been referred to as mesenchymal undifferentiated connective tissue [1,12]. Accordingly, Tcf4-positive fibroblasts in mesenchymal connective tissue have been described as a key factor in muscle morphogenesis in developmental mouse and chick models [6,9].…”
Section: Introductionmentioning
confidence: 99%